Form 144 Filer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF...
AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN PR Newswire EMERYVILLE, Calif., April 5, 2023...
8-K0001365916FALSE00013659162023-04-032023-04-03 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
Table of Contents As filed with the Securities and Exchange Commission on March 31, 2023 File...
8-K0001365916FALSE00013659162023-03-172023-03-17 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
TABLE OF CONTENTSAs filed with the Securities and Exchange Commission on March 16, 2023File Number 333-255105 UNITED STATES SECURITIES AND...
0001365916FALSE00013659162023-03-152023-03-15 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
Table of Contents As filed pursuant to Rule 424(b)(7) Registration No. 333-255105 PROSPECTUS...
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS PR Newswire EMERYVILLE, Calif., March...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
8-K0001365916FALSE00013659162023-03-102023-03-10 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023 PR...
8-K0001365916FALSE00013659162023-02-132023-02-13 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
GIVAUDAN TO ACQUIRE PORTFOLIO OF MAJOR COSMETIC INGREDIENTS FROM AMYRIS AND TO ESTABLISH STRATEGIC PARTNERSHIP...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.